Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2026-01-08 @ 6:49 AM
Study NCT ID:
NCT02186834
Status:
COMPLETED
Last Update Posted:
2023-01-04
First Post:
2014-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
Sponsor:
Organization: